Neobiosis Email Format
Biotechnology ResearchFlorida, United States11-50 Employees
Neobiosis is a privately owned, clinical-stage biotechnology CDMO that concentrates on isolating tissues, cells, and extracellular vesicles from donated perinatal birth tissues, such as the umbilical cord, cord blood, and amniotic fluid. The company operates two production facilities in downtown Gainesville, Florida. Its research and development activities are conducted in an accompanying laboratory located within the Sid Martin UF Innovate biotechnology Institute in Alachua, Florida. Neobiosis serves client organizations seeking to advance biomedical products through FDA-approved clinical trials toward commercialization in the global market. The firm derives products from healthy full-term births and aims to cultivate an internal pipeline of intellectual property and biologicals for use in anti-aging and regenerative medicine. Positioned within the biotechnology research sector, the company operates as a small to mid-sized provider of development and manufacturing services for perinatal-derived biologics.